Information Provided By:
Fly News Breaks for September 27, 2016
IPXL
Sep 27, 2016 | 07:35 EDT
Goldman analyst Stephan Stewart upgraded Impax to Neutral citing balanced risk/reward and limited pricing risk. Stewart raised Impax's price target to $26 from $25.
News For IPXL From the Last 2 Days
There are no results for your query IPXL